2024-09-02 - Analysis Report
## PFE Stock Analysis

**Company Overview:** Pfizer Inc. is a multinational pharmaceutical corporation that develops and produces medicines and vaccines. 

**1. Performance vs. S&P 500 (VOO):**

* **Cumulative Return (PFE):** -26.27%
* **Cumulative Return (VOO):** 89.66%
* **Performance Gap:** -115.93% (Relative IGD: 1.28)

**Interpretation:** PFE has significantly underperformed the S&P 500 over the period examined. Its cumulative return is significantly lower, indicating a weaker performance than the market benchmark. The Relative IGD of 1.28 suggests that this underperformance is relatively consistent with its historical performance.

**2. Recent Price Action:**

* **Closing Price:** $29.01
* **5-Day Moving Average:** $28.84
* **20-Day Moving Average:** $28.85
* **60-Day Moving Average:** $28.80

**Interpretation:** The stock price is currently hovering around its 5, 20, and 60-day moving averages, indicating a period of consolidation or sideways trading.

**3. Technical Indicators:**

* **RSI:** 60.69
* **PPO:** -0.02
* **Delta_Previous_Relative_Divergence:** -11.82 (Short-term downward trend)
* **Expected Return:** 0.0% (5-year maximum expected return)

**Interpretation:**  The RSI value suggests that PFE is currently in a neutral territory, neither overbought nor oversold. The negative PPO value indicates a potential weakness in price momentum. The negative Delta_Previous_Relative_Divergence suggests a short-term downtrend in the stock's relative strength. However, the Expected Return remains neutral, indicating a lack of significant upside or downside potential in the foreseeable future.

**4. Recent Earnings & Outlook:**

| Date        | EPS    | Expected EPS |
|-------------|--------|--------------|
| 2024-07-30  | 0.6    | 0.458         |
| 2024-05-01  | 0.82   | 0.516         |
| 2024-01-30  | 0.1    | -0.19         |
| 2023-10-31  | -0.17   | -0.32         |
| 2023-08-01  | 0.67   | 0.56          |

**Interpretation:** The recent earnings report shows that PFE has been exceeding earnings estimates. The most recent quarter (2024-07-30) delivered an EPS of 0.6, exceeding the expected 0.458. This positive trend indicates strong performance and potential for future growth.

**5. Overall Analysis:**

* PFE has underperformed the market significantly, but its recent earnings performance suggests potential for future growth.
* Technical indicators are currently neutral, but the short-term downward trend in relative divergence suggests caution.
* The Expected Return remains neutral, indicating a lack of significant upside or downside potential in the foreseeable future.

**6. Conclusion:**

Overall, PFE presents a mixed picture. While its recent earnings performance is encouraging, its underperformance compared to the S&P 500 and the current short-term downtrend in its relative strength suggest a cautious approach. Investors should closely monitor the stock's performance and further developments to assess its long-term potential. 
